PharmaCyte Biotech Inc - ESG Rating & Company Profile powered by AI
Check the end of this webpage for potential risks for PharmaCyte Biotech Inc based on sector, geography and size. The webpage displays a free E,S&G analysis for PharmaCyte Biotech Inc. This analysis of PharmaCyte Biotech Inc was assembled by All Street Sevva using cutting edge AI.
PharmaCyte Biotech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | PharmaCyte Biotech Inc | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does PharmaCyte Biotech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes PharmaCyte Biotech Inc report the average age of the workforce?
Sign up for free to unlockDoes PharmaCyte Biotech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes PharmaCyte Biotech Inc offer flexible work?
Sign up for free to unlockDoes PharmaCyte Biotech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes PharmaCyte Biotech Inc conduct supply chain audits?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes PharmaCyte Biotech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose water use targets?
Sign up for free to unlockDoes PharmaCyte Biotech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid PharmaCyte Biotech Inc have a product recall in the last two years?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes PharmaCyte Biotech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas PharmaCyte Biotech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose parental leave metrics?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes PharmaCyte Biotech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes PharmaCyte Biotech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs PharmaCyte Biotech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose its waste policy?
Sign up for free to unlockDoes PharmaCyte Biotech Inc report according to TCFD requirements?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose energy use targets?
Sign up for free to unlockDoes PharmaCyte Biotech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes PharmaCyte Biotech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for PharmaCyte Biotech Inc
These potential risks are based on the size, segment and geographies of the company.
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.